Cerebral

Online mental-health startup Cerebral Inc. was just getting off the ground in early 2020 when it detected a potential problem in its business model. The company was focused on treating people experiencing depression and anxiety, charging a monthly fee to see a nurse practitioner online for prescription antidepressants. But patients tended to cancel their subscriptions after only a few months, making it more difficult for the company to recoup advertising and other costs, according to documents reviewed by The Wall Street…

CVS pharmacies will no longer fill prescriptions for controlled substances like Adderall from telehealth companies Cerebral and Done Health, The Wall Street Journal reported. It’s the latest blow to Cerebral, which is facing investigations from the US Department of Justice and the Drug Enforcement Administration. Cerebral said last week that it was going to stop prescribing controlled substances to new customers, and would transition existing customers off of the service by the fall. The company told The Wall Street…

CVS Health Corp. will stop filling prescriptions for controlled substances ordered by clinicians working for Cerebral Inc. and Done Health starting Thursday, a move that will impact thousands of patients. Cerebral disclosed the change in a statement to The Wall Street Journal. The pharmacy plans to block Done prescriptions for controlled substances as well, according to a person familiar with the matter. CVS didn’t immediately respond to a request for comment.…

Cerebral Inc. has replaced Chief Executive Kyle Robertson, according to a statement released by the company, a move Mr. Robertson called illegal after accusing board members of making him a scapegoat for the mental-health startup’s troubles.The board said in the statement that it has replaced Mr. Robertson with David Mou, the company’s president and chief medical officer. The leadership tumult comes as the company is facing a federal probe into its prescription…

Directors who control the board of Cerebral Inc. agreed on a plan to replace Chief Executive Kyle Robertson, sparking leadership tumult at the mental-health startup as it contends with scrutiny over its prescription practices for controlled substances, people familiar with the situation said Tuesday. Investors and an independent director who together control four of the board’s seven seats agreed that Mr. Robertson should be replaced by the firm’s president and chief medical officer, David…

Online mental-health company Cerebral Inc. said it would stop prescribing almost all controlled substances, expanding an overhaul of its treatment practices in the wake of scrutiny over how it provided stimulants for attention-deficit hyperactivity disorder. Kyle Robertson, Cerebral’s co-founder and chief executive, wrote in an email to staff on Monday afternoon that the company would stop prescribing controlled substances, excluding those in one category, for new patients effective …

Mental health startup Cerebral is under investigation by the US Department of Justice over its prescribing of controlled substances like Adderall and Xanax. The company received a grand jury subpoena asking for documents from the US Attorney for the Eastern District of New York on May 4, Insider first reported. The company said the same day that it was pausing its prescriptions for controlled substances for new patients. Cerebral offers therapy and counseling for conditions like anxiety, insomnia, and ADHD. Unlike some…

Cerebral Inc., the online mental-health company, said on Saturday it has been subpoenaed by federal prosecutors as part of an investigation into possible violations of the Controlled Substances Act. Cerebral, one of a group of telehealth startups that have sprung up to treat attention-deficit hyperactivity disorder, said the grand jury subpoena was received on Wednesday from the U.S. attorney’s office for the Eastern District of New York. Cerebral said the subpoena was issued to Cerebral…

Online pharmacy company Truepill Inc. said it is temporarily halting prescriptions for Adderall and other controlled substances used to treat attention-deficit hyperactivity disorder, and partner Cerebral Inc. told its clinicians to direct those orders to patients’ local pharmacies.Cerebral, an online mental-health company based in San Francisco that describes Truepill as its preferred pharmacy, informed its clinicians of Truepill’s decision in a Friday email viewed by The Wall Street Journal. The email said Truepill…